Curis, Inc. to Present at the 8th Annual Needham Life Sciences Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at the 8th Annual Needham Life Sciences Conference at 1:00 p.m. EDT on June 10, 2009, at the New York Palace Hotel in New York City.

Back to news